Mucomat Hustenstiller (Pentoxyverine Citrate)

Pentoxyverine Citrate, the active ingredient in Mucomat Hustenstiller, is an antitussive presented as an oral formulation for systemic use. It suppresses dry, non‑productive coughs in adults and adolescents, providing symptomatic relief without narcotic effects and may improve sleep quality during nighttime episodes generally.

GNH USA supplies Mucomat Hustenstiller as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals and clinics worldwide, ensuring consistent quality and regulatory compliance across markets and reliable delivery for a broad range of therapeutic needs.

Mucomat Hustenstiller, containing pentoxyverine citrate, acts on the central cough pathway to reduce cough reflexes.

Dry cough: reduces frequency and intensity of non‑productive cough episodes in patients with irritation of the respiratory tract. Bronchial irritation: alleviates cough caused by mild bronchial irritation without producing mucus. Upper respiratory tract irritation: provides symptomatic relief of cough associated with common colds.

Pentoxyverine citrate may cause several adverse reactions, most of which are mild and reversible.

Common Side Effects: - Drowsiness: mild sleepiness, especially after initial doses. - Dry mouth: reduced salivation leading to throat discomfort. - Nausea: occasional stomach upset after ingestion. - Dizziness: transient light‑headedness, usually self‑limiting.

Serious or Rare Side Effects: - Allergic skin reactions: rash, urticaria, or angioedema requiring medical attention. - Hallucinations or confusion: rare central nervous system disturbances. - Hepatic enzyme elevation: abnormal liver function tests observed in isolated cases.

When prescribing or dispensing Mucomat Hustenstiller, consider the following precautions. - Assess hypersensitivity: verify patient has no known allergy to pentoxyverine or similar antitussives. - Monitor in hepatic impairment: use with caution in patients with liver disease. - Avoid in children under 12: safety not established for young age groups. - Caution with CNS depressants: may increase sedation when combined. - Pregnancy and lactation: discuss risk‑benefit with healthcare provider. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Pentoxyverine citrate can interact with other medicines; review patient medication lists.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Alcohol: additive central nervous system depression. - Opioid antitussives: excessive cough suppression may occur.

Moderate Interactions (Monitor Closely): - Other CNS depressants (benzodiazepines, antihistamines): may enhance sedation. - CYP3A4 inhibitors (e.g., erythromycin): may increase plasma levels of pentoxyverine. - Antihypertensive agents: possible additive hypotensive effect.